T he condition of 5-alpha-reductase type 2 deficiency (5-ARD) is an inherited disorder resulting in the inability to convert testosterone to dihydrotestosterone (DHT). [1] [2] [3] [4] This disorder was previously termed as familial incomplete male pseudohermaphroditism type 2, pseudovaginal perineoscrotal hypospadias. 1, 2 Clinical manifestation of 5-ARD is limited to male genetic. [1] [2] [3] [4] The affected males are usually identified as female in childhood but undergo striking virilization at puberty. 2, 3 While overall incidence for various countries are not established, increased incidence is reported in the Dominican Republic, some highland tribes in New Guinea, Lebanon and Turkey. [5] [6] [7] [8] This was the first documented case in Cipto Mangunkusumo (CM) Hospital.
dl (normal: 284.2 -946.6 ng/dl) and dihydrotestosterone level was 14 ng/dl (normal: 30 -85 ng/dl). After hCG test, testosterone level increased to 752 ng/dl and dihydrotestosterone level decreased to 12 ng/dl. Testosterone to dihydrotestosterone ratio was 63:1. Bone age revealed average boy (Greulich-Pyle standard). Abdominal ultrasound revealed the absence of uterus.
The diagnosis of this patient was 5-alpha-reductase deficiency. The parents were informed about this disorder. The patient and family were consulted to a child psychiatrist. Psychological evaluation revealed that the patient adopted male identity. Treatment with 50 mg testosterone per dose given intramuscularly, 4 times, in 3 weeks interval was started. External genitalia reconstruction was planned to perform after hormonal treatment. Psychosocial support was started as soon as the diagnosis was established. After the third dose of testosterone therapy, the penis length showed no improvement, so the dose of testosterone was increased to 250 mg per dose with 4-week interval.
Discussion
The differentiation of genital ducts begins around the fourth week of gestation when the Wolffian ducts develop. The presence of fetal testis determines further direction of genital duct differentiation in male. 9,10 ( Figure 2) 5-ARD is an autosomal recessive sex-linked condition resulting in the inability to convert testosterone to the more physiologically active DHT. Since DHT is required for the normal masculinization of the external genitalia in utero, genetic males with 5-ARD are born with ambiguous genitalia. They are usually identified as female at birth, 2,3,10,11 as in this case.
The described clinical abnormalities range from infertility with normal male genital anatomy to underdeveloped male with hypospadias to predominantly female external genitalia, most often with mild clitoromegaly. 2, 12 Phenotypic findings in a newborn are limited to the genitalia. Most commonly, the external genitalia exhibit labial appearance to the labioscrotal folds with some mild rugation or pigmentation, clitoris-like phallus, perineoscrotal hypospadia, and pseudovagina blind ending introitus. The testes are usually in the inguinal canals bilaterally; however, in some individuals with 5-ARD, the testes can be found in the labioscrotal folds or retained in the abdomen. Clear signs of virilization predominate at puberty. The phallus exhibits definite enlargement. The shoulders are relatively broad and the hips are narrow, muscularity may increase, and generally no occurs at puberty and may be attributable to the rise in type-1 enzyme activity at that time. 16, 17 Thus, DHT, the most potent androgen, is bound selectively to the androgen receptors in genital skin and fibroblasts, making its action necessary for the development of normal male genital anatomy in the fetus. 1, 2, 13 Studies in the Dominican Republic, Turkey, New Guinea, Sweden, Brazil, Mexico, and the Middle East showed the mutation of SRD5A2 located at band 2p23 in 5-ARD. [6] [7] [8] 13, [15] [16] [17] [18] Chavez et al showed the evidence of uniparental disomy in 5-ARD and revealed an alternate mechanism whereby this enzymatic disorder can be derived from a single parent. 19 There is no correlation between severity of the genetic defect and phenotype. 3,13 DNA analysis was not done in this case.
The biochemical diagnosis is based on finding normal to modestly elevated serum testosterone level, low to undetectable serum DHT level, with markedly increased basal and especially, hCGstimulated testosterone to DHT ratio (>17), and high ratio of urinary etiocholanolone to androsterone and 5b to 5a cortisol metabolites, low activity of 5-alpha-reductase in fibroblast cultured from genital skin and positive mutation analysis of SRD5A2. 3, 4, 12, 20, 21 Basal testosterone to DHT ratio in healthy prepubertal children is 3, and at puberty is 12. 22 The normal level of testosterone in breast development. A prominent Adam's apple may start to develop, scanty hair usually presents, and the voice may begin to deepen. The uterus and fallopian tubes are absent due to the normal secretion of the Müllerian-inhibiting factor. Testes are intact, as are wolffian structures such as epididymis, vas deferens, and seminal vesicles. 1, 2, 11, 13 In this case, the patient came at late puberty (A3P4G4) with perineoscrotal hypospadia, bifid scrotum, micropenis, intact testes, and the absence of uterus.
A deficiency of the type 2 of isozyme 5-alphareductase, which transforms testosterone to DHT, is the root cause of this disorder. 1,2,13 Two genes coding for 5-alpha-reductase have been identified, each for a slightly different isoenzyme. 2, 14 The gene for 5-alpha-reductase type 1 has been determined to be on chromosome 5. Its product is expressed only after birth. Chromosomal analysis was performed to determine the genotype of the patient. 2, 13 Chromosomal analysis in this case revealed 46 XY. Abdominal ultrasound can verify the location of the testes and the absence of uterus. 2 In this case, abdominal ultrasound showed the absence of uterus. If pseudovagina is found, a vaginogram is a useful tool to assess vaginal length and fistulous connections between the urinary tract and vagina. Histological findings in the testes exhibit leydig cell hyperplasia. However, testicular biopsy is not a part of the routine evaluation. 2, 13 Bone age is done to examine bone maturation. 13 This patients was still in potential genetic height and his bone age revealed average boy. These showed the normal growth of the patient.
Diagnosis of 5-ARD is based on clinical findings, pedigree analysis, biochemical and radiological findings. 2, 3, 13, 16, 20, 23 No risk factor or any clinical marker in There were labioscrotal folds (arrow) (E) with testes in palpation, micropenis with perineoscrotal hypospadia (arrow) (F) found in physical examination of the sister. Fig (G) The patient with his sister pregnancy are known. Prenatal diagnosis with mutation analysis is rarely done in 5-ARD. 2 The diagnosis in this patient was established at late puberty, if it was performed earlier, the patient and family would be more prepared physically and psychologically, especially in gender transition.
The differential diagnosis of 5-ARD is partial androgen insensitivity syndrome (PAIS). The PAIS is an X-linked disorder, in which partial virilization and gynaecomastia can be found at puberty. DHT level in PAIS is normal. 2, 3 Management of 5-ARD is started with gender assignment. Almost all children with 5-ARD are assigned as female gender at birth. More than 70% of individuals with 5-ARD adopt male gender identity and male gender role at puberty. However, the remainders continue living in the female role and gender identity. [23] [24] [25] If the patient adopts male gender identity and micropenis is found, hormonal therapy with 2% of DHT cream should be immediately started. 2, 23 Some evidence suggests that high dose of 250-500 mg testosterone therapy or DHT may enhance virilization. 23, 26 Testosterone and DHT therapy are more effective to be administered before puberty. 23 External genitalia reconstruction such as urethroplasty for hypospadia is done after hormonal therapy. 1, 23 In this patient, after psychological evaluation revealed male gender identity, high dose of testosterone therapy was administered at late puberty. DHT 2% cream is still not available in Indonesia. Urethroplasty was planned to perform after hormonal therapy. If the patient adopts female gender identity, gonadectomy, genitoplasty, and hormone replacement therapy with estrogen are recommended. Estrogen is administered to stimulate secondary sex development and to prevent bone mineralization. 2, 23 Psychosocial support for the patient and family is important especially in gender transition. [23] [24] [25] A multidisciplinary team approach, including pediatric endocrinologist, child psychiatrist, plastics surgeon or pediatric surgeon or pediatric urologist, and geneticist, is needed in diagnosis and management of 5-ARD. 2, 23 5-ARD is not life threatening; if intraabdominal testes are retained, an increased risk of gonadoblastoma exists. A risk of osteoporosis increases in gonadectomy without hormone replacement therapy. 2 A deficiency in DHT production results in a highly viscous semen and an extremely low volume of ejaculate, although sperm counts may be normal; this may impair fertility. 27 Katz et al described the use of intrauterine insemination with sperms from a man with this disorder and a history of infertility. The first pregnancy gave rise to a normal son and the second pregnancy produced fraternal twins. 28 Psychological morbidity due to gender or sexual identity issues is usually complex. 2 In this patient, cryptorchidism was not found and gonadectomy was not performed. So the risk of gonadoblastoma and osteoporosis may not exist. Psychological morbidity and infertility problem may occur in this patient's life.
